Dr. Reddy's Laboratories (RDY) Q1 2013 Earnings Call July 19, 2012 9:00 am ET Executives Kedar Upadhye - Former Director Umang Vohra - Chief Financial Officer, Executive Vice President and Member of Management Council
Kallam Satish Reddy - Managing Director, Chief Operating Officer, Executive Director, Member of the Management Council, Chairman of Management Committee, Member of Shareholders Grievance Committee, Member of Investment Committee and Member of Strategy Committee Analysts Balaji V. Prasad - Barclays Capital, Research Division Nimish Mehta - MP Advisors Arvind Bothra - BofA Merrill Lynch, Research Division Ravi K. Agrawal - Standard Chartered plc, Research Division Manoj Garg - Edelweiss Capital Ltd., Research Division Sameer Baisiwala - Morgan Stanley, Research Division Anubhav Aggarwal - Crédit Suisse AG, Research Division Bino Pathiparampil - IIFL Research Bhavin Shah - Dolat Investments Ltd., Research Division Ranjit Kapadia - Centrum Broking Private Limited, Research Division Nitin Agarwal - IDFC Securities Ltd., Research Division Abhay Shanbhag - Deutsche Bank AG, Research Division Saion Mukherjee - Nomura Securities Co. Ltd., Research Division Chirag Talati - Espirito Santo Investment Bank, Research Division PresentationOperator Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q1 FY '13 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand over the conference to Mr. Kedar Upadhye. Thank you, and over to you, sir. Kedar Upadhye Good morning, and good evening to all, and thank you for joining us today for Dr. Reddy's Earnings Call for quarter 1 of fiscal '13.